Hypertension · 1992 · 189 citations · 12 references
MedicinePharmacologyPhysiologyBiochemical PharmacologyExperimental PharmacologyPharmacodynamicsBlood Pressure RegulationCardiovascular PharmacologyCardiovascular PhysiologyAntihypertensive PharmacologyIn Vivo StudiesPlasma Renin ActivityRenin-angiotensin System InhibitorsRenin-angiotensin-aldosterone System Inhibitors
We investigated the processing enzymes involved in the formation of circulating angiotensin-(1-7) after intravenous administration of angiotensin I to conscious spontaneously hypertensive and Wistar-Kyoto rats. Immunoreactive products, including angiotensin I, angiotensin II, and angiotensin-(1-7), were measured in arterial blood by three specific radioimmunoassays. Angiotensin I infusion (2 nmol) induced a rapid increase in immunoreactive angiotensin II and angiotensin-(1-7). Pretreatment with the angiotensin converting enzyme inhibitor enalaprilat (2 mg/kg) eliminated angiotensin II formation and augmented circulating levels of angiotensin I and angiotensin-(1-7) in spontaneously hypertensive and Wistar-Kyoto rats. The elevated levels of angiotensin-(1-7) in enalaprilat-treated rats were blocked by concurrent treatment with the neutral endopeptidase (EC 3.4.24.11) inhibitor SCH 39,370 (15 mg/kg) in both strains. Administration of SCH 39,370 alone decreased angiotensin-(1-7) levels in spontaneously hypertensive rats, whereas angiotensin II levels increased in both strains (p less than 0.01). Comparisons of the metabolism of angiotensin I in the two rat strains showed increased formation of angiotensin-(1-7) in spontaneously hypertensive rats not given any of the enzyme inhibitors. In addition, levels of angiotensin I were higher after administration of SCH 39,370 in hypertensive rats. These novel findings reveal that neutral endopeptidase EC 3.4.24.11 participates in the conversion of angiotensin I to angiotensin-(1-7) and in the metabolism of angiotensin II in the circulation of both spontaneously hypertensive and Wistar-Kyoto rats. Our results suggest that neutral endopeptidase EC 3.4.24.11 is a major enzymatic constituent of the circulating renin-angiotensin system.
12
Identification of angiotensin-(1-7) in rat brain
Mark C. Chappell, K. Bridget Brosnihan, Debra I. Diz et al. · Journal of Biological Chemistry · 1989 · 211 citations · Full text
Converting enzyme activity and angiotensin metabolism in the dog brainstem.
Robson A.S. Santos, K. Bridget Brosnihan, Mark C. Chappell et al. · Hypertension · 1988 · 183 citations · Full text
Angiotensin(1–7) in the spontaneously hypertensive rat
Katsuhiko Kohara, K. Bridget Brosnihan, Carlos M. Ferrario · Peptides · 1993 · 154 citations
Medicine, Pharmacology, Physiology +10